FEATURED ARTICLES

• Collaborative Approach Is Key To Successful CGT Clinical Trials

  Cell and gene therapies (CGT) offer hope for innovative treatments, but complex trials strain healthcare resources. Explore how the impact of resource strain delays these transformative therapies for patients in need.

• Azzur Serves NC Biosciences With "Cleanrooms On Demand"

  Find out how a national life sciences service company is helping North Carolina startups by providing state-of-the-art facilities in Morrisville for product development and manufacturing to accelerate growth and streamline operations.

• Celebrating Women's Innovation In Life Sciences

  North Carolina's life sciences ecosystem thrives due to visionary women leaders. Discover their groundbreaking contributions in biotechnology and executive roles that drive global impact.

• RTP Company Advancing Sample Prep Through Microfluidics Technology

  Discover how Redbud Labs is revolutionizing sample preparation with cutting-edge microfluidics technology and their innovative platform that enhances laboratory efficiency.

• IMMvention Therapeutix Collaborates With Novo Nordisk

  IMMvention Therapeutix partners with Novo Nordisk to develop oral therapies for sickle cell disease. Discover how this partnership and their innovative Bach1 inhibitors could transform treatment.

• NC Universities Earn Prestigious R1 Designation For Research Activity

  East Carolina University and UNC Charlotte have achieved R1 status. Discover how their significant research contributions enhance North Carolina's reputation as a life sciences hub amid rising business establishments.

• North Carolina Life Sciences Growth Outpaces Nation

  North Carolina's life sciences sector surpasses 100,000 jobs and continues to outpace industry growth. Learn more about the key findings and future opportunities for North Carolina.

• North Carolina Booked Over $10 Billion In Life Sciences Investments

  Discover how 4,500 jobs were created across 16 communities and how North Carolina achieved a record-breaking year by securing over $10 billion in life sciences investments.

• Wet Lab Incubator Space Launching In Chapel Hill In Early 2025

  A new wet lab incubator space is set to launch in 2025 to foster biotech innovation. Follow along to gain insight into the progress and how this facility will support startups.

• Durham's Tune Therapeutics To Conduct First Epigenetic Therapy Trial

  Tune Therapeutics will launch the first human trial of an epigenetic therapy, TUNE-401, targeting chronic Hepatitis B, a major global health threat affecting millions.

• CRO Summit Seeks To Boost Collaboration Between Sponsors And CROs

  The inaugural CRO Summit in Raleigh gathered 200+ attendees to enhance sponsor-CRO collaboration, explore technology integration, and discuss AI’s cautious adoption in clinical trials.

• Accelerate NC: Empowering Underserved Populations To Pursue Careers In NC Life Sciences

  Accelerate NC strengthens North Carolina's life sciences sector by expanding inclusive workforce training programs and creating economic opportunities that drive transformative statewide economic impact.

• Amgen Plans Over $1B Expansion In North Carolina, Creating 370 Jobs

  Amgen is expanding its Holly Springs, N.C., biomanufacturing site with a $1.018 billion investment, adding 370 jobs, advancing sustainability, and bolstering North Carolina's life sciences leadership.

• OpiAID Brings New Tech To Help 'Neighbors' Caught Up In Opioid Crisis

  David Reeser’s OpiAID leverages wearable tech and data analytics to combat opioid addiction, fostering trust, personalizing treatment, and partnering with leading institutions for innovative solutions.

• CSL Seqirus Gets $155.4M For Pandemic Vaccine Production

  Global vaccine maker, CSL Seqirus, has received federal grants totaling $155.4 million to expand production of an avian influenza vaccine. Read more about this pandemic-preparedness initiative.

• North Carolina: A Rising Hub For Radiopharmaceutical Innovation

  Radiopharmaceuticals are on the brink of transforming cancer treatment and diagnostics. Learn more about how North Carolina has become the epicenter of this radioactive drug revolution.

• Early-Stage Startups Meet Potential Investors, Partners

  This year's Triangle Venture Day set the stage for investors from across the nation to learn about the latest innovations in medical technology. Read more about the people and ideas behind this event.

• Consumer Products Company Reckitt Investing $145M In Wilson Pharma Manufacturing Site

  Learn about the major life sciences investment made by Reckitt Benckiser to establish a pharmaceutical manufacturing facility to produce over-the-counter medication Mucinex in Wilson, North Carolina.

• Johnson & Johnson To Invest $2B On New Biologics Facility In Wilson, Create 420 Jobs

  Gain insight into the promising life sciences investment a global healthcare and medtech company is planning to make for a new biologics manufacturing facility focusing on the production of mAbs.

• NCBiotech's Influence Reaches Across NC And The US

  In the 1980s, North Carolina emerged as a hub for biotechnology. Learn how a state-supported, accelerator-style entity, played a crucial role and continues to nurture the state's life sciences landscape.